Planned website maintenance is taking place from 11:00 pm AEDT on Friday 30 October to 6:00 am AEDT on Saturday 31 October 2026. Some pages may be temporarily unavailable. If issues continue outside this time, please contact us.
Sponsor content
359 result(s) found, displaying 291 to 300
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VELMETIA 50/850 sitagliptin (as phosphate monohydrate) 50 mg and metformin hydrochloride 850 mg tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VELMETIA 50/500 sitagliptin (as phosphate monohydrate) 50 mg and metformin hydrochloride 500 mg tablet blister pack.
-
Designation or determinationPriority review
-
Prescription medicine registrationActive ingredients: ezetimibe.
-
Prescription medicine registrationActive ingredients: pembrolizumab (rch).
-
Cancellation by sponsorRequested by Merck Sharp & Dohme (Australia) Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PNEUMOVAX 23 pneumococcal purified capsular polysaccharides 25 microgram/0.5mL injection pre-filled syringe.
-
Designation or determinationOrphan drug
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for JANUMET XR 100/1000 sitagliptin(as phosphate monohydrate)/metformin hydrochloride 100 mg/1000 mg extended release tablet bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for JANUMET XR 50/1000 sitagliptin (as phosphate monohydrate)/metformin hydrochloride 50 mg/1000 mg extended release tablet bottle.